Taken together, ERBB4 signaling adjacent to the T2DM and renal cell carcinogenetic mechanism subnetworks can be studied as potential promising targets and biomarkers for T2DM-associated renal cell carcinoma. This evidence concerns the gene ERBB4 and hereditary clear cell renal cell carcinoma.